![Food and Drug Administration / Pharmacology / Therapeutics / United States Public Health Service / Whistleblower / United States Office of Special Counsel / Pharmaceutical sciences / Clinical research / Clinical pharmacology Food and Drug Administration / Pharmacology / Therapeutics / United States Public Health Service / Whistleblower / United States Office of Special Counsel / Pharmaceutical sciences / Clinical research / Clinical pharmacology](https://www.pdfsearch.io/img/14c90b12990f37866dbbe9b5d684d426.jpg) Date: 2014-02-26 11:10:07Food and Drug Administration Pharmacology Therapeutics United States Public Health Service Whistleblower United States Office of Special Counsel Pharmaceutical sciences Clinical research Clinical pharmacology | | Statement of Senator Charles E. Grassley Before the United States House of Representatives Committee on Oversight and Government Reform Hearing, “Limitless Surveillance at the FDA: Protecting the Rights of Federal WhisAdd to Reading ListSource URL: oversight.house.govDownload Document from Source Website File Size: 85,43 KBShare Document on Facebook
|